Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,901,109 | $1,860,539 | $2,181,189 | $3,038,391 |
| % Growth | 2.2% | -14.7% | -28.2% | – |
| Cost of Goods Sold | $659,399 | $564,895 | $693,608 | $607,903 |
| Gross Profit | $1,241,710 | $1,295,644 | $1,487,581 | $2,430,488 |
| % Margin | 65.3% | 69.6% | 68.2% | 80% |
| R&D Expenses | $473,925 | $592,010 | $1,084,665 | $868,069 |
| G&A Expenses | $745,429 | $468,958 | $552,192 | $592,219 |
| SG&A Expenses | $1,175,484 | $911,215 | $1,023,336 | $1,128,958 |
| Sales & Mktg Exp. | $430,055 | $442,257 | $471,144 | $536,739 |
| Other Operating Expenses | -$269,568 | -$369,279 | $1,210,307 | -$338,484 |
| Operating Expenses | $1,379,841 | $1,133,946 | $3,318,308 | $1,658,543 |
| Operating Income | -$138,131 | $161,698 | -$1,830,727 | $771,945 |
| % Margin | -7.3% | 8.7% | -83.9% | 25.4% |
| Other Income/Exp. Net | -$290,157 | -$322,958 | -$292,051 | -$275,932 |
| Pre-Tax Income | -$428,288 | -$161,260 | -$2,122,778 | $496,013 |
| Tax Expense | $43,261 | $96,427 | $196,794 | $253,119 |
| Net Income | -$216,662 | -$54,017 | -$1,914,918 | $416,509 |
| % Margin | -11.4% | -2.9% | -87.8% | 13.7% |
| EPS | -0.023 | -0.006 | -0.21 | 0.044 |
| % Growth | -303.4% | 97.2% | -575.1% | – |
| EPS Diluted | -0.023 | -0.006 | -0.21 | 0.044 |
| Weighted Avg Shares Out | 9,265,984 | 9,297,246 | 9,329,999 | 9,431,297 |
| Weighted Avg Shares Out Dil | 9,265,984 | 9,297,073 | 9,329,999 | 9,483,383 |
| Supplemental Information | – | – | – | – |
| Interest Income | $175,548 | $147,908 | $146,794 | $163,948 |
| Interest Expense | $274,931 | $269,337 | $211,176 | $117,351 |
| Depreciation & Amortization | $258,426 | $226,233 | $369,807 | $255,493 |
| EBITDA | $105,069 | $334,310 | -$1,541,795 | $931,690 |
| % Margin | 5.5% | 18% | -70.7% | 30.7% |